Category: Covid-19 Vaccine

Page 526«..1020..525526527528..540550..»

See where you line up for COVID-19 vaccine when its available, thanks to NYT tool – WHNT News 19

December 24, 2020

FLORENCE, Ala. Florence-Lauderdale Animal Services Director Cheryl Jones said while a new dog or cat may seem ideal for a Christmas gift, customers should strongly consider what goes into it.

"We just feel that owning a pet is a very personal decision and oftentimes matching a pet to their person is really important, Jones said.

Jones said that gifting a pet as a surprise causes the animal and the recipient to miss out on much-needed bonding time before the adoption.

"Some people don't want a puppy, Jones said. They require a lot of training, they require a lot of energy, so we try to match a person and a pet so that it'll be a good experience for the person but also a good experience for the pet."

When adopting a shelter animal, Jones said many people don't realize that a number of the animals have been displaced and lived whole other lives before the shelter.

"And then to be given as a gift to a place that's not good for the pet or the person, is an additional stressor, Jones said.

Some animals can adjust to the change in environment, but Jones said adapting is a little harder for others, leading to behavioral issues.

There's also the time commitment that goes along with being a pet owner. "I just tell people who are looking for puppies, if you don't want to raise another child, then don't get a puppy because you're going to have to be teaching and training and they could livepets can live 12, 15, in some cases 20 years, Jones said.

Jones said all of this is not to deter people from adopting, but to remind them of the responsibility that's expected when adding that new four-legged family member.

Jones said anyone who wants to visit the shelter for the adoption process, they're doing appointments only to limit the number of people inside for COVID-19 precautions. She said the shelter is willing to do anything it can to help customers find that special friend.

Read the original here:

See where you line up for COVID-19 vaccine when its available, thanks to NYT tool - WHNT News 19

Borough Assembly approves amended COVID-19 vaccination resolution – KRBD

December 24, 2020

The Ketchikan Gateway Borough Assembly on Monday approved an amended resolution regarding COVID-19 vaccinations.

There were two separate COVID-19 resolutions up for consideration. The first, proposed by Borough Mayor Rodney Dial, asked businesses not to deny services based on a persons COVID-19 vaccination status or refusal to provide that information. That resolution failed Monday night due to lack of motion.

The second, proposed by assembly members Judith McQuerry and Austin Otos, encourages citizens to get the COVID-19 vaccine. They argued vaccinating the Ketchikan community would help the economy reopen, while also recognizing an individuals right to choose.

Over the course of more than two hours of discussion, three amendments were brought forward for discussion.

The first, proposed by Assembly Member David Landis added wording similar to that in Mayor Dials proposal, urging businesses not to discriminate against people who arent vaccinated. The amendment passed 5-2 with McQuerry and Assembly Member Felix Wong voting against.

The second amendment, proposed by Assembly Member A.J. Pierce, added a recital recognizing the different issues and circumstances each member of the community faces and acknowledging, especially in a time of crisis, every citizen deserves to be treated with kindness and good will. That amendment passed unanimously.

The third amendment was added to a section encouraging citizens to get the COVID-19 vaccine, but stating that each community member needs to make an educated decision in deciding if getting the vaccine is right for them. The amendment passed 5-2 with McQuerry and Wong voting against.

Assembly Member Jeremy Bynum noted in some sections, the resolution recognized the vaccine is not mandatory, but in others indicated people could opt out. He felt these were contradictions. He proposed an amendment to remove the phrase opt out. The amendment failed due to lack of a second.

After considering delaying action, the Assembly chose to vote on the amended resolution that combined language from Mayor Dials original non-discrimination initiative. It passed 6-1 with Bynum voting against.

The resolution is non-binding.

Go here to see the original:

Borough Assembly approves amended COVID-19 vaccination resolution - KRBD

Two COVID-19 vaccines are now authorized in the US; here’s what we know about them – USA TODAY

December 22, 2020

The COVID-19 vaccine is using new technology that has never been used before in traditional vaccines. Here's how an mRNA vaccine works. USA TODAY

Two COVID-19vaccines are now authorized in the United States.

The Moderna vaccinebegan arriving across the nationMonday, just three days after it was authorized for emergency use by the Food and Drug Administration.It comes onthe heels of the Pfizer-BioNTech vaccine, which is being given to health care workers and nursing home residents.

As Americans prepareto get vaccinated, manyalsohave questions.What's the difference between these two vaccines, how effective are they, and when do we all expect to get them?

Heres what we know about the COVID-19 vaccines and what theymightmean forthe pandemic.

Pfizer and the German biotechnology company BioNTech developed one of the COVID-19 vaccines that has been authorized by the FDA, BNT162b2.

Moderna, a Cambridge, Massachusetts-based biotechnology company, developed a COVID-19 vaccine, mRNA-1273, that was authorized Friday.

All of the late-stage vaccine trials include at least 30,000 volunteers, half of whom receive the active vaccine and half the placebo.

Both vaccines require two doses. The Pfizer-BioNTech shots are being given 21 days apart.Modernas are given 28 days apart.

Beginning a week after the second dose, participants are watched to see whether they come down with COVID-19.

In each of the studies, after about 150 participants have developed COVID-19, it is statistically possible to determine the vaccine's effectiveness.

Almost 200 trial participants developed symptomatic COVID-19 in the Moderna trial, only 11 of whomhad received the active vaccine. Because the infection rate was so much higher in the placebo group, statistical analysis determined that the vaccine was 94% effective overall, according to safety and effectiveness data released Dec. 15.

Pfizer/BioNTech reported on Nov. 18 that of 170 confirmed cases of COVID-19 among its trial participants, 162 were in the placebo group versus eight in the vaccine group. A safety and effectiveness report released Dec. 8 confirmed thefindings.

In Modernas Phase 3 trials, the company said the most common side effects were fatigue, muscle soreness and aches, joint pain and headache, plus pain, redness or swelling at the injection site.

In Pfizer/BioNTech Phase 3 trials, many participants endured side effects for a day or two after getting their shots, particularly the second one. The most commonly reported side effect among vaccine recipients under age 55 was a sore arm, followed by fatigue (60% after the second shot); headache (52% after the second shot); other muscle aches (37%); and chills (35%). About 28% took pain medication after the first shot and 45% after the second shot.

A sore arm and feeling crummy for a day or two is a lot better than COVID, said Dr. William Schaffner, professor of health policy and of preventive medicine at the Vanderbilt University School of Medicine.

Physicians emphasize that the side effects are not just normal but also a sign that the body is reacting properly to the vaccine.

Side effects of theCOVID-19 vaccines look similar to side effects of the influenza vaccine, which includesoreness, redness, and/or swelling where the shot was given, headache, low-grade fever, nausea, muscle aches and fatigue, according to the Centers for Disease Control and Prevention.

In trials of 44,000 and 30,000 respectively, Pfizer/BioNTech and Moderna saw very few problemsmore serious than a couple of days of feeling lousy.

Four people in the Pfizer/BioNTech trial and three people in the Moderna trial developed Bell's Palsy, a neurological condition that leads to temporary drooping of one side of the face.

At least two people in Great Britain, where the vaccine was first approved and distributed, as well as several Americans have had powerful allergic reactions to the Pfizer-BioNTech vaccine so far, representing a tiny fraction of those vaccinated. The federal government is studying these reactions but has so far said the vaccine appears to be safe for anyone who has not previously had an allergic reaction to one of the vaccines' ingredients.

Most of the U.S.-backed vaccines target the spike protein found on the surface of the virus that causes COVID-19, which allows the virus to attach itself to host cells and infect them.

Both of these vaccines work by presenting this spike protein to the immune system. The spike proteins arent dangerous because the rest of the virus isnt present;however, the body now sees the protein and designs immune "soldiers" to fight it.

The Moderna and Pfizer vaccines deliver strands of genetic material known as mRNA, which turns peoples cells into spike protein factories.

In this special edition episode of States of America, experts answer the biggest questions Americans have about the vaccine, side effects, how it's getting to you and more. USA TODAY

This technology has never been used before in an approvedvaccine, though it has been tested against other diseases. The mRNA technology was chosen this time because scientists knew it could be developed quickly.

Other COVID-19 vaccine candidates being supported by the U.S. government target the spike protein via a different carrier virus or tiny particle.

The vaccines require different types of storage.

The Pfizer/BioNTech vaccine must be kept super-cold at the temperature of dry ice until shortly before it is used.The Moderna vaccine needs to be frozen if stored for a long time, but it can be refrigerated for up to a month before being used.

Since the Pfizer/BioNTech vaccine has been approved, health care workers and people in long-term facilities across the country have been lining up to get their scheduled vaccine.

A few high-profile politicians, such as Vice President Mike Pence and Florida Sen.Marco Rubio, were publicly vaccinated in hopes of instilling confidence in the vaccine.

A CDC advisory panel decided Sunday that police, firefighters, teachers and grocery workers will be among the next in line for a COVID-19 vaccine.

The committee vote recommended that Phase 1b include people 75 and older and front-line essential workers. They make up about 30 million people among these groups:

Because vaccine supplies are initially limited, Phase 1b isnt expected to begin until February.

Phase 1c will include people 65 to 74 and people 16 to 64 who have high-risk medical conditions, along with other essential workers. This would make up about 57 million people and would include:

Phase 2 would include all people 16 and over who were not in Phase 1 who are recommended for the vaccination. That means people 16 and over with high-risk medical conditions.

Coronavirus updates: Moderna vaccinations set to begin Monday; New York Gov. Cuomo urges feds to ban flights from UK

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told the USA TODAY Editorial Board Nov. 18that he expectedthe general public to begin vaccinations as early as April.

Contributing: Karen Weintraub and Elizabeth Weise, USA TODAY. Follow Adrianna Rodriguez on Twitter: @AdriannaUSAT.

Health and patient safety coverage at USA TODAY is made possible in part by a grant from the Masimo Foundation for Ethics, Innovation and Competition in Healthcare. The Masimo Foundation does not provide editorial input.

Autoplay

Show Thumbnails

Show Captions

Read or Share this story: https://www.usatoday.com/story/news/health/2020/12/21/covid-vaccine-pfizer-biontech-moderna-everything-know-them/3955331001/

Read more here:

Two COVID-19 vaccines are now authorized in the US; here's what we know about them - USA TODAY

CEO of Howard University Hospital got the Covid-19 vaccine to encourage staff to follow her lead – CNN

December 22, 2020

The CEO of Howard University Hospital, a major health care provider for the African American community in Washington, DC, was well aware that her employees and staff had reservations about the vaccine. And that notion frightened her.

An internal hospital survey of about 350 employees in early November found that 70% were not willing to take the vaccine or would not take it immediately after it became available.

Even her own leadership team was hesitant. "I'll take it if you take it," some members told her.

"I said, 'I will gladly take it first,'" Jenkins told CNN.

So Jenkins received the first dose of the Pfizer vaccine on December 15 before cameras to instill confidence in the vaccine among her staff, becoming the latest high-profile health care professional to take such a step.

Alleviating her employees' fears has been a slow process, but Jenkins said she's optimistic.

Howard University Hospital received 725 doses of the Pfizer vaccine in its first shipment, with more vaccines expected this week. To date, the hospital said more than 350 staffers have received the vaccine out of the nearly 2,300 employees, residents and contractors who work there.

The numbers, while still low, exceeded expectations, Jenkins said. She added that the hospital expects to run out of its initial 725 doses "well ahead of schedule."

Building up trust has been a slow process

Jenkins' move is part of a widespread effort by community leaders and health care experts to combat vaccine hesitancy among Black and Latino Americans -- a particularly pressing problem given the disproportionate toll that the virus has taken on those communities.

Of those people, the majority said they were concerned about possible side effects; half were worried they would get Covid-19 from taking the vaccine; and 48% said they have a general distrust in vaccines.

Communities of color have "every right to be nervous," Jenkins said.

"This is not an American experiment on Black people," Jenkins said. "This is a worldwide pandemic with a worldwide vaccine as a solution to the thousands of deaths."

Since learning that so many staffers at Howard University Hospital did not yet feel comfortable taking the vaccine, Jenkins said she and her team have been putting out Q&As to address people's concerns.

She has also been personally answering questions from employees: Could they possibly get Covid-19 from the vaccine? What were the side effects? Was it safe for pregnant women? What about nursing mothers? What about those who were trying to get pregnant?

"I felt personally responsible to help people through not just misunderstandings, but misinformation, and to help them through their fears," Jenkins said.

The messages have continued even after she took the vaccine: Is she experiencing any side effects? (Nothing besides a sore arm the first day.) What about 48 hours later? (Still feeling good.) What about a week later? (Doing just fine).

That so many Black and brown people -- even those she's never met -- are coming to her with their fears and concerns has been humbling, Jenkins said. And it's a reminder of just how important it is for experts and professionals who look like the communities they serve to take the vaccine.

"I hope they trust us more because we can relate," Jenkins said. "I hope that they see us as one of them."

Other Black leaders have done the same

Dr. Valerie Montgomery Rice recently sent a similar message to Black Americans.

Rice, too, empathized with some Black Americans' concerns over the nation's history of racism in medicine. But she insisted that she wouldn't recommend a vaccine she didn't trust.

"We are in the rooms where it's happening," Rice said. "So we clearly are not going to go against ourselves. Because we understand how critical this is for Black America and Latinx America who have been disproportionately impacted by the virus."

Morehouse is among the historically Black colleges and universities, Black sororities and fraternities and prominent Black pastors who are leading national efforts to remove the stigma around the Covid-19 vaccine.

Other cornerstones in Black communities, like barbershops and hair salons, have also been playing a key role in the conversation. Stephen Thomas, a professor of health policy and management at the University of Maryland in College Park, is hosting Zoom town halls where doctors and scientists teach Maryland-based barbers, stylists and their clients about the vaccine.

The effort is part of Thomas' initiative Health Advocates In-Reach and Research, or HAIR, that provides cancer screenings at barbershops and hair salons.

"The barbers and the stylists have trust," Thomas said. "It's a big deal, it's a family affair. It's a place where Black people come together across all their socioeconomic divisions."

CNN's Nicquel Terry Ellis contributed to this report.

Follow this link:

CEO of Howard University Hospital got the Covid-19 vaccine to encourage staff to follow her lead - CNN

When will Oregon EMS workers receive COVID-19 vaccine? – KOIN.com

December 22, 2020

Oregon nurses and doctors have been receiving the COVID-19 vaccine. Are EMTs and paramedics next in line?

by: Amanda Arden

PORTLAND, Ore. (KOIN) Oregons first frontline medical workers began receiving the Pfizer COVID-19 vaccine Wednesday, and an official with Metro West Ambulance says the states first EMS workers will likely be vaccinated by the end of this week.

KOIN 6 News spoke to Shawn Baird, vice president of rural services for the Metro West family of companies, on Monday. Hes been communicating with the Oregon Health Authority on distributing the vaccine to paramedics and EMTs.

According to Baird, the first group of EMS workers who will receive the vaccine, among the Metro West companies, will be in Clatsop County. Their vaccinations will likely occur before the end of the week. Baird said these EMS workers are receiving them first because theyve partnered with a hospital in Astoria to receive an allocation of vaccines.

Baird said its hard to say which EMS workers will receive the vaccines next. It depends on availability and on how each county distributes them.

Hopefully over the coming weeks, with any luck, theyre talking about numbers that we could, maybe, by the first of the year have most all of our licensed staff vaccinated, Baird said.

After nurses and doctors at local hospitals began receiving the vaccine on Wednesday, Dec. 16, some people contacted KOIN 6 News saying they were concerned EMS staff wouldnt be prioritized with other frontline workers.

However, according to the Oregon Health Authoritys Phase 1a Vaccine Sequencing Plan, EMS providers and other first responders are included in the first group of health care personnel who will be vaccinated.

Non-emergency medical transport personnel are included in Group 3.

Baird said nothing has changed and EMS workers are still among the first in line to receive the vaccine, its just going to take some time to get everyone in Group 1 vaccinated.

Last week we started seeing the first shipments trickle into Oregon, but we saw, I dont know the exact number, a few thousand doses come in and we have hundreds of thousands of eligible healthcare workers, Baird explained.

He said its possible some paramedics will receive the vaccine before others, depending on the kind of risks they face in their daily duties. He said some paramedics treat more COVID-19 patients than others.

According to Baird, not all of Metro Wests EMS staff in each county will be vaccinated on the same day. He said they want to make sure they have enough staff available in case some people have a reaction to the vaccine.

He said hes optimistic that as the Moderna vaccine is shipped to Oregon, it will be easier to get to more EMS workers in rural parts of the state, since its a more stable vaccine and doesnt need to be stored at such a low temperature.

Follow KOIN 6 for the latest news and weather

More:

When will Oregon EMS workers receive COVID-19 vaccine? - KOIN.com

How top EHR vendors are prepping their systems for COVID-19 vaccines – Healthcare IT News

December 22, 2020

Never in the history of electronic health records has there been a more important public health recordkeeping task than the one that is at hand at this very moment in the nations history: tracking COVID-19 vaccinations.

As a result of this all-important development, EHR vendors from across the industry have been preparing their products and their healthcare provider organization users to make sure that when a patient receives this critical vaccination, it is recorded correctly, pushed to the necessary parties, and is accessible now and in the future by all the appropriate caregivers.

Healthcare IT News discussed this huge issue with top executives at Allscripts, athenahealth, Cerner, DrChrono, Epic, Greenway Health, Meditech and NextGen Healthcare.

HIMSS20 Digital

They offered insights into preparations that began earlier this year, described the changes theyve made to their EHR systems and discussed how theyve been rolling out and helping train for these new design and workflow changes.

Meditech has had its Coronavirus Task Force up and running this year, assisting clients through all stages of their pandemic response.

As word of a vaccine started to circulate, we were already working with customer advisory boards to determine what steps would be needed for preparation, looking to our Immunization Registry and patient registries as solutions for tracking and reporting on vaccine administration, said Helen Waters, executive vice president at Meditech. We are fully vested in ensuring our customers are well-positioned to hit the ground running.

The EHR maker said of course its work required guidance from the CDC, HHS, public health officials and industry organizations. These efforts ramped up on Oct.29, when the company attended the CDC Operation Warp Speed Town Hall.

Helen Waters, Meditech

Here, the CDC informed us of the vaccine codes that would be available and urged vendors to build these codes into their system ASAP, Waters explained. Since the codes were released on Nov.12, we have updated our customers by sharing these codes along with vaccine guidance. Also, we immediately began working with our interoperability team to review the CDCs HL7 draft specifications.

Meditech continues to attend weekly EHRA/CDC breakout meetings to monitor evolving updates provided by the CDC. In addition, it is collaborating with its Meditech User Group, MUSE, and soliciting feedback from its customer base through email surveys.

Providing the solutions and guidance to support our customers through this critical venture and bring an end to this pandemic remains Meditechs top priority, with all divisions fully invested in these efforts, Waters said.

Cerner began preparing for potential COVID-19 vaccines back in April as cases were rising in the U.S. It then ramped up efforts by mid-summer to make sure its solutions and clients were ready.

At that time, Cerner recognized that some of its clients would play a community-wide vaccination role and would need a patient-first strategy that included tools outside of the companys core EHR workflow.

When it became clearer in October that an approved vaccine was likely in early 2021, we engaged with the CDC and some of its information technology suppliers in order to successfully interoperate with federal and state registries, said Dr. David Nill, vice president and chief medical officer at Cerner. We needed to make sure that our clients were ready on the IT front to handle such a monumental and important task.

Cerner was able to put in place many of its model recommendations for the fall flu campaign, gaining insights to modify the workflow based on recommendations for COVID-19 vaccine administration, he added.

At NextGen Healthcare, preparations for vaccine administration and reporting began several months ago. Dr. Robert Murry, chief medical information officer, said the EHR vendor initially focused on the four areas most important to its ambulatory clients:

EHR company athenahealth has been focused on rapidly responding to the COVID-19 pandemic and supporting its customers all year.

We made the first COVID-driven changes available to all our practices back on Jan.29 when there were only a handful of confirmed cases in the U.S., said Paul Brient, chief product officer at athenahealth. We deployed COVID screening questions, diagnostic test ordersand direct links to the latest CDC recommendations to all our providers overnight.

Dr. David Nill, Cerner

The vendor is fortunate to have a cloud-based, single-instance EHR that enables changes to be made quickly and immediately available to all provider clients, he added.

Since then, we have pushed out approximately 150 updates ranging from updated assessment content to align to initial CDC travel and exposure guidance, to updated code sets for COVID-19, to patient testing and risk dashboards for our practices to monitor their panels, to workflow enhancements for remote and in-car check in all delivered immediately in the cloud to the entire athenahealth network, he explained.

The companys preparedness for a COVID-19 vaccine began in spring 2020. It kicked off a research effort to understand how its practices were managing their patient populations with risk stratification, patient outreach and testing protocols. It also spent time learning what it could from experience with past flu vaccination efforts. All these learnings are foundational to identifying and engaging patients as COVID-19 vaccines become available, Brient said.

As more details of vaccines emerge, we have a team of subject matter experts working to understand the requirements and distribution guidelines defined by the federal government and states in order to provide best practice workflow recommendations and support to our practices, he said.

This includes staying abreast of registry updates, partnering with clients that are participating in early vaccination efforts,and making updates to our global compendiums and code libraries as soon as they are available.

Allscripts has been participating in conversations with HHS, the CDC and Operation Warp Speed through the course of the pandemic, most recently meeting weekly to address the need to track and report vaccine administration.

The good news is that there are no changes yet from a federal perspective that require EHR development because we have met the existing ONC certification requirements associated with connectivity to immunization registries, said Leigh Burchell, vice president of government affairs at Allscripts.

The only area in which we are finding ourselves having to do new development specific to tracking the COVID-19 vaccines is where some states are requesting the transmission of unique data elements. We certainly favor a more consistent approach rather than the state-by-state adjustments to what is necessary to be reported.

Dr. Robert Murry, NextGen Healthcare

At Greenway Health, the primary concern is ensuring its healthcare organization clients have what they need to properly document immunizations and communicate with patients and government bodies seamlessly without any workflow disruptions.

As pharmaceutical companies began their efforts to develop COVID-19 vaccines in earnest with Operation Warp Speed, Greenway Health simultaneously initiated a cross-company initiative to ensure our two EHR solutions were enhanced to support our ambulatory care providers as they began to administer the vaccines, said Dr. Michael Blackman, chief medical officer.

In parallel, Greenway Health participated alongside other EHR vendors in Electronic Health Records Association-led discussions with the CDC, HHS and the state immunization registries to stay abreast of the fast-moving events related to the rollout of the vaccine. As an industry, its vital that EHR vendors all fully understand and meet the governments data requirements that are required by providers to fulfill, Blackman said.

Daniel Kivatinos, COO and co-founder of DrChrono, said his companys product is a flexible software platform.

The platform has an electronic medical records app with powerful technology that enables a medical practice to build a practice in a bespoke way, he said. With different options for tracking fields, a practice for example can select a custom field creating a field tied to the medical record for COVID-19 vaccines allowing data points and record keeping.

DrChrono also offers other fields that can be created in the custom note, along with tailored tagging. Depending on the practice, a care team can configure the EHR to best suit their needs, he added.

At EHR giant Epic, the company recently released software updates specific to the COVID-19 vaccine. Dr. Nichole Quick, who works on the clinical informatics team at Epic, explained that these updates include:

The vendor is adding these updates to an array of tools, Quick said, that customers already use to facilitate and track tens of millions of annual vaccine administrations:

Meditech said it views vaccine distribution holistically, taking into account the importance of patient safety, the speed with which this has to happen, the volume of individuals who are going to need to be vaccinated, and the timeframe and sequence of the vaccine requirements.

Our approach is to remain agile, as there are a number of factors to consider, including the different vaccine manufacturers, eligibility phases by state, whether the patient is known or unknown to a facility, whether the patient has comorbidities and risk factors, and where the vaccine will be administered, said Waters of Meditech. Vaccine distribution requires careful collaboration across all venues of care, as well as across all distribution sites across the community.

Paul Brient, athenahealth

To guide its clients, Meditech is providing best practice guidance and scenarios for vaccine administration across each of its integrated care areas (for example, practice, acute, ED, LTC and clinics) to ensure the best possible outcome, Waters added.

We understand that vaccine administration is not a one-size-fits-all approach, so were preparing our customers for a variety of scenarios, she said. As frontline workers will be among the first vaccinated, were tracking them in our EHR. Registries will be available to identify other eligible patients for vaccine distribution according to phase-based guidelines and FDA and CDC recommendations.

For those patients known to an organization, clinicians benefit from embedded clinical decision support, which helps identify patients who are high-risk or immunocompromised, including those with severe allergies or pre-existing conditions and women who are pregnant, she said. Clinicians can view comprehensive EHR data, including allergies and medications, to identify potential risks or conflicts based on FDA guidelines, she added.

In addition, they can see if a patient is under treatment for other conditions, Waters explained. We are also providing a short form, web-based mobile solution that supports the capture of the COVID-19 immunization quickly from any venue such as a drive-up site without an appointment and medical record on file. This is particularly important for high-volume vaccination sites, where the patient is not always known to the health system.

Since the vaccine will be distributed in two doses, it is equally important to accurately track and share which dose was given and when. Meditech is enabling its clients to track vaccine distribution across its EHR and communicate important distribution details with state, federal and third-party sources, including distribution date, dose and manufacturer, Waters said.

Per CDC guidelines, our system will produce a certificate as proof of the individuals vaccination to present as required, she said. We also offer a bidirectional immunization registry to report vaccine administrations to the state, and to verify whether a patient has received a first dose elsewhere and which pharmaceutical company manufactured that dose.

Leigh Burchell, Allscripts

But the safest way to ensure a patient receives the correct second dose is by having that patient return to the same location, Waters contended. To encourage this, Meditechs scheduling solution includes inherent decision support to drive the vaccine appointment sequence, with proactive confirmation and reminders shared with the patient, she explained.

Finally, we are making it easy for our customers to seek appropriate reimbursement from a program or plan that covers related COVID-19 vaccine fees by patient, without charging the patient, she said. Our emphasis is on achieving these goals as efficiently as possible. This will be a large-scale endeavor, and creating solutions that work for a variety of scenarios is imperative. We are approaching this challenge as an opportunity to support our customer needs in an agile manner.

Cerner is preparing end-to-end model workflow recommendations for U.S. and non-U.S. healthcare organization clients that incorporate patient outreach, scheduling opportunities, clinician administration best practices, billing, and reporting and analytics tracking after administration.

Reminder outreach is essential because some COVID-19 vaccines require two doses for full efficacy, said Nill of Cerner.

The recommendations also can include an optional mass vaccination solution at no cost to our clients, helping to supplement rapid vaccination without sacrificing safety checks or administration documentation, he explained. Mass vaccination procedures help make it quick to register patients, identify vaccines needed and document administration of vaccines at a large scale.

For example, Boston Childrens Hospital has successfully used Mass Vaccination this fall to expand its flu vaccination efforts to its parking garage and additional non-office based clinics.

The EHR maker has reached out to clients big and small, urban and rural, to understand their plans and best support and prepare their EHR domains appropriately ahead of receiving the vaccine, Nill added.

In addition, we have offered several webinars, office hours and client workflow discussions to prepare the ideal socially distanced workflow, including drive-through vaccination, he said.

Athenahealth has healthcare organization clients participating in some of the first vaccinations. Even before the emergency use authorizations were approved, and as NDC, CVX and MVX assignments were being finalized, the EHR maker updated its drug compendium to include available COVID-19 vaccine orderables. Brient said the company has been working to understand how best to support these early sites and respond in near-real time to make sure they are successful.

We will continue to stay very close to the evolving guidance and protocols from CMS, he said. In addition, we are examining our entire vaccine and patient management workflow so that we can best support our clients in this very important and unique effort. Both the transition to high numbers of telehealth visits and the high volume of COVID testing have necessitated important changes to our software.

Dr. Michael Blackman, Greenway Health

The high volumes of vaccines (and unique requirements such as two-dose vaccines) similarly require changes to the core athenaOne workflows to allow practices to operate optimally, Brient added.

We have a cross-divisional working group that is considering all our clients diverse needs and is spearheading enhancements and workflow guidance across a myriad of use cases, he noted. This includes identifying patients, or healthcare workers, who are high priority for a vaccine; engaging patients around COVID vaccination; managing the coordination and scheduling of patients across the two vaccine doses; properly documenting vaccinations according to guidelines; and reporting across clinical measure, registry and billing needs.

All enhancements will be deployed immediately to all clients as soon as they are available, he added.

At NextGen Healthcare, the vaccine administration workflow will be identical in the NextGen Enterprise EHR to other vaccines.

As an ambulatory EHR vendor, we have thousands of practices administering a variety of vaccines currently, with some practices administering hundreds of vaccines a day now for example, large pediatric practices, said Murry of NextGen Healthcare. So all of the workflows, safeguards, handoffs, inventory controls, billing mechanisms, automated reporting, etc., that are currently well-known will be utilized for COVID-19 vaccines as well.

The EHR and population health tools enable providers to document the particular vaccine provided to each patient. Once the reporting requirements at the state and federal level become available, the mode of transfer of this data and the specific data elements can be determined, he said.

The most important thing is that at least at this point there should not be major changes to EHR workflow, said Blackman of Greenway Health.

Clinicians should be able to administer vaccines the way they always do, and our products can transmit this information to state immunization registries, he said. There are certain new optional data elements the CDC is requiring from registries, such as identifying demographic priority groups. The registries may, in turn, require these additional elements from providers.

Dr. Nichole Quick, Epic

The vendor said it continues to monitor the situation closely as this aspect is still in flux.

From a product development standpoint, we are making sure that the clinical terminology sets our products rely on include the necessary drug and procedure codes to support the COVID-19 vaccines, and that our interoperability connections with state registries continue to facilitate immunization reporting, he noted.

Over the past several weeks, Epic healthcare provider organization clients have joined webinars led by Epic experts who have walked through system setup and recommended operational workflows.

Most of the changes weve made to the software that are specific to the COVID-19 vaccine are turned on automatically, so theres very little manual setup involved allowing our customers to focus on adjustments that are specific to their organization, Quick explained. Weve also published written guidance that ranges from high-level, executive-facing recommendations to detailed technical instructions.

Most of the development for the COVID-19 vaccine already is complete, and the final updates will be finished and available to clients worldwide by the end of December, she added.

Meditechs most important concern has been determining how to record the vaccine data and leverage the depth of an integrated EHR as efficiently as possible.

Weve supplied customers with build guidelines for new vaccine codes and easy access to frequently asked questions to make them aware of preparations they can make today to be ready to administer these vaccines as they become available, said Waters of Meditech. Training is the key to success. Our customer service team works with customers daily on training and preparedness to ensure content has been updated and modified to reflect this guidance.

Key guidance includes how to enter data quickly into the system and how to create appointment reminders to assist with COVID-19 vaccination preparation. Meditech also is training clients on its new mobile offering for high-volume vaccine administration locations for individuals who are not patients of a health system.

One of the benefits of our EHR is its flexibility, Waters contended. As updated guidelines become available, we will continue to proactively communicate with our customers through a variety of channels.

Right now, athenahealth is working jointly with its clients that are participating in early vaccine distribution to understand their needs and support them as those needs evolve, Brient said.

A key element of this work is to formally document our learnings so we can provide training and coaching for clients as we roll out enhancements and workflow recommendations, he said. This training is provided in informative best practices guides within our software. As we did in the early days of the COVID-19 pandemic, we will make these enhancements immediately available to all our clients across our cloud-based EHR as soon as they are ready.

The goal is that most users will be able to adopt these changes without training, but for users who need training or have unique workflows, the company has named customer success managers who can provide any additional support clients need to begin successfully administering, managing and recording vaccines, he added.

Since DrChrono has a cloud-based EHR, it is able to roll out new features and enhancements every week; it trains users on new features weekly via ongoing webinars, posting information to its YouTube channel and putting updated content in its knowledge base.

We have a dedicated account management team that works to keep our user base informed, Kivatinos said. We are accustomed to making changes fast; for example, when COVID-19 hit the United States, the DrChrono team created a large effort quickly to roll out a telehealth solution, creating a telehealth offering within a short window and training our user base on the telehealth offering.

Murry of NextGen Healthcare said most users do not need additional training since the workflow is similar to what they already use for vaccination management and reporting.

The key difference will be new specific COVID-19 coding, he explained. Tracking would need to be improved to strip out, document and record only COVID-19 vaccination information for transmission to the CDC. We are working toward making the first system changes that allow documentation of vaccine administration with the new CPT/CVX codes available to our clients as soon as possible.

Communication with clients will be more critical than the training aspect because each states circumstances are different, he said.

We are meeting with all constituents by specialty and market to help them prioritize a plan for their specific situation.

Twitter:@SiwickiHealthITEmail the writer:bsiwicki@himss.orgHealthcare IT News is a HIMSS Media publication.

Follow this link:

How top EHR vendors are prepping their systems for COVID-19 vaccines - Healthcare IT News

Now That Grandma Has Been Vaccinated, May I Visit Her? – The New York Times

December 22, 2020

A watershed moment has arrived for many families: This week health care workers from CVS and Walgreens, under contract from the federal government, will fan out to nursing homes across the country to begin vaccinating residents against the coronavirus. The shots not only will help protect the nations elderly and infirm and the staff who care for them but they raise the prospect of ending the devastating isolation many residents have felt for months.

Family members are hopeful that before too long, they will return to visiting parents and grandparents, aunts, uncles and other loved ones regularly again. We checked with experts on some common questions.

Probably not in a big way. Restrictions vary by state, and the federal governments guidance on what it considers safe stands for now. They already allow visits under certain conditions. The Centers for Medicare & Medicaid Services, or C.M.S., recommended in September that outdoor visits with residents be allowed and indoor visits, too, if the facility has been free of cases for 14 days.

Some medical experts have said that those guidelines are too lax and that visits should be severely restricted, even banned. However, some of these experts are now saying that the vaccine changes the equation, somewhat.

Once all residents are vaccinated, it opens the door for loosening of restrictions, said Dr. Michael Wasserman, the immediate past president of the California Association of Long Term Care Medicine, a geriatrician and former executive at nursing home chains.

To allow visits, Dr. Wasserman recommends all residents of a nursing home should be vaccinated (unless they have some condition or allergy that would discourage vaccination on medical grounds); all staff members should be vaccinated; and the nursing home should have the ability to ensure that visitors test negative for the coronavirus and have been disciplined about wearing a mask in public settings.

The clinical trials of the Pfizer and Moderna vaccine included people over 65, and results showed it to be safe and to work as well in older people as in younger ones.

This vaccine has gone through testing and clinical trials to ensure it meets the highest safety standards. It also is safe to get if you already had the virus, says a campaign to encourage people to get the shots by the American Health Care Association and National Center for Assisted Living, a combined trade group representing nursing homes and assisted-living communities.

The lead administrator for C.M.S., Seema Verma, reinforced the confidence in the shot for older patients, including those with health conditions, in a statement last week: I urge states to prioritize nursing homes and vulnerable seniors in their distribution of the vaccine.

The point is echoed by Dr. Sabine von Preyss-Friedman, chief medical officer of Avalon Health Care Group, which operates nursing homes, who said the new vaccines appear safe and effective.

With distribution of a coronavirus vaccine beginning in the U.S., here are answers to some questions you may be wondering about:

The Pfizer and Moderna vaccines both require two injections the initial shot and a booster three or four weeks later. Dr. von Preyss-Friedman recommends waiting at least two weeks after the second shot to have a visit.

You hope these vaccines work, but these are elderly patients, she said. You want to err on the side of protection.

She said that, ideally, the visitor would also be vaccinated as well. Since shots wont be widely available for a few months, it may be best to wait until you get your vaccine. Until then, she believes nursing homes should consider visits on a case-by-case basis.

Absolutely, medical experts said. This is particularly true if they are not vaccinated, but even after they are vaccinated until rates in the community go down, said Dr. Joshua Uy, a geriatrician and associate professor at the University of Pennsylvania Medical School and the medical director of Renaissance Healthcare & Rehabilitation Center, a nursing home in Philadelphia.

Dr. Uy said that he hopes that the federal government would supply enough personal protective equipment so that all visitors and residents could be properly gowned for such visits.

The combined nursing-home and assisted-living trade group has started a program aimed at helping nursing homes and other care facilities to explain to residents the essential need to get the vaccine. The campaign, #getvaccinated, notes: The elderly population has a much higher risk for getting very sick, being hospitalized, or dying from Covid-19. The vaccine has been shown to provide a great deal of protection against serious illness due to Covid-19.

But the people they love most may have more effective persuasive powers. Families can help, Dr. Uy said, by encouraging their parents and grandparents in nursing homes to get vaccinated.

The vaccine, he said, is going to be our way out.

Follow this link:

Now That Grandma Has Been Vaccinated, May I Visit Her? - The New York Times

Amid evolving strains, COVID-19 vaccines likely need updates every 3 years, former FDA chief Gottlieb says – Fox News

December 22, 2020

Former Food and Drug Administration Commissioner Scott Gottlieb said Monday coronavirus vaccines will likely require updates every few years as surface proteins on the virus evolve to become unrecognizable to antibodies.

Gottlieb told CNBC co-hosts that while current COVID-19 vaccines and prior immunity are likelyeffective against the newly mutated strain of the virus rapidly circulating in the U.K., the evolving virus will necessitate surveillance by sequencing.

CORONAVIRUS MUTATION NOT VACCINE-RESISTANT, CURRENT, FUTURE SURGEON GENERALS BELIEVE

"We thought every two, or maybe three years, I was saying that probably 6-8 months ago, every three years, that might still be the case," Gottlieb said, referring to a potential timeframefor updated COVID-19 vaccines. "I dont think this is something we need to update every season, but if it becomes easy to update it, you may do that, you may look at what the predominant strain is and try to update it more regularly."

U.K. Prime Minister Boris Johnson has warned the mutated strain could be 70% more transmissible, though this figure was based on earlyprojections and there is still significant uncertainty around the issue. Nevertheless, Johnson announced Tier 4 restrictions over the weekend, ushering in new lockdowns in London and southeast England to curb the spread of the mutated virus strain.

CUOMO: UK'S COVID-19 MUTATION 'IS ON A PLANE TO JFK' WITHOUT TESTING

Officials have said mutations in viruses are quite common, and while the flu evolves and requires an updated vaccine annually, Gottlieb expects the virus causing COVID-19 disease, SARS-CoV-2, to evolve at a slower pace. However, some viruses cannot change their surface proteins, such as the measles, the former FDA chief said.

"We now think that this is more transmissible," he said."It doesnt seem to have mutated the surface proteins of the virus in a way that they would slip past our vaccines or prior immunity, in fact, we dont think that thats the case.

"But what this does suggest is that the virus probably will evolve its surface proteins in a way that they wont be recognized by the antibodies we have right now and we will have to update the vaccines."

GET THE FOX NEWS APP

Gottlieb added that using the entire spike protein in the vaccines will prove beneficial due to a so-called polyclonal response.

"Were developing antibodies to many different regions of that protein, so even if one part of that protein were mutated, and some antibodies no longer recognize it, there would be antibodies to other parts of that protein," he explained.

The former FDA head says a future framework for updating COVID-19 vaccines will likely pivot around antibody responses or so-called immunogenicity data. However, scientists are still working to understand what level of induced antibodies will offer lasting protection.

Gottlieb also flagged possible issues stemming from antigen and antibody tests, potentially primed to a specific region of the spike protein, and upon change,the virus "could potentially slip past those tests."

The news comes as Johnson sets to convene the government's emergency committee Monday after France closed its borders to arrivals from the U.K. to stem the spread of the new strain.

The Associated Press contributed to this report.

See the original post:

Amid evolving strains, COVID-19 vaccines likely need updates every 3 years, former FDA chief Gottlieb says - Fox News

Police, firefighters, teachers will be next in line for COVID-19 vaccine – Yahoo News

December 22, 2020

Police, firefighters, teachers and grocery workers will be among those next in line for a COVID-19 vaccine, a Centers for Disease Control and Prevention advisory panel decided Sunday.

The committee voted 13-1 to recommend that Phase 1b include people 75 and older and front-line essential workers. Phase 1c will include people 65 to 74 and people 16 to 64 who have high-risk medical conditions, along with other essential workers.

"My hope is that these short-term recommendations will support efficiency and equity in every phase of vaccination until we can get to the time when all individuals have access to safe and effective vaccines in the U.S. and worldwide," said Dr. Grace Lee, a professor of pediatrics at Stanford University School of Medicine and committee member.

The Advisory Committee on Immunization Practices began its deliberations Sunday morning and spent the day discussing who would follow front-line health care workers and people in long-term care facilities in receiving vaccines, a second phase that could begin in February. The committee is responsible for recommending who gets what vaccines when.

They made difficult decisions that were based on getting a vaccine as quickly as possible to people at the greatest risk of contracting COVID-19 and those who will suffer the most severe outcomes, said Dr. Sharon Fry of the Saint Louis University Medical School and a committee member.

"There are no perfect recommendations. and people will continue to become ill with this disease and die from the disease until there are adequate vaccines. So please, I will plead also for our leaders and the government to move quickly on this and support this effort," she said.

There are now two COVID-19 vaccines in use in the United States. The Pfizer/BioNTech vaccine was authorized by the Food and Drug Administration on Dec. 11. The Moderna vaccine was authorized Friday and should begin arriving at hospitals on Monday.

The United States has created a phased vaccination plan for the coronavirus because there won't be enough vaccine in the beginning of the rollout.

Phase 1a includes front-line health care workers and people in long-term care facilities.

"Essential workers are at high risk because of exposure, by virtue of being in contact with others, in performing their duties. Prevention of disease in essential workers may reduce transmission to others," said Dr. Kathleen Dooling, a CDC physician who is co-lead on the advisory committee's COVID-19 Vaccines Working Group.

These workers are considered essential to the functioning of society and are at substantially higher risk of exposure to SARS-Co/V-2, the virus that causes COVID-19. They make up about 30 million people among these groups:

First responders such as firefighters, police

Teachers, support staff, day care workers

Food and agriculture workers

Manufacturing workers

Correction workers

U.S. Postal Service workers

Public transit workers

Grocery store workers

Tho essential workers in Phase 1c make up about 57 million people and would include:

Public health workers

Transportation and logistics workers

Food service workers

Construction workers

Finance workers

IT & Communications workers

Energy workers

Media workers

Legal workers

Public safety engineers

Water and wastewater workers

Medical conditions with sufficient evidence to have been associated with severe COVID-19 disease include:

Obesity

Type 2 diabetes

COPD, or chronic obstructive pulmonary disease

Heart condition

Chronic kidney disease

Immunocompromised state from solid organ transplant

Sickle cell disease

Pregnancy

Smoker (current or with a history of smoking)

Phase 2 would include all people 16 and over who were not in Phase 1 who are recommended for the vaccination. That means people 16 and over with high-risk medical conditions.

Because vaccine supplies are initially limited, Phase 1b isn't expected to begin until February.

Operation Warp Speed, the White House COVID-19 vaccine and treatment accelerator, has said it expects to distribute 20 million doses in December, 60 million in January and 100 million by February. That's 180 million doses by the end of February, which means 90 million people would be fully vaccinated. (Both the Pfizer/BioNTech and Moderna vaccines require two doses.)

Exactly how the 20 million doses will be distributed by the end of the month is not clear. Last week, 2.9 million doses of the Pfizer/BioNTech vaccine were distributed. This week, another 2 million doses of the Pfizer vaccine will be distributed, together with 5.9 million doses of the Moderna vaccine.

More vaccines are in the pipeline. Another candidate, from Johnson & Johnson, fully enrolled its large-scale human trial Thursday and expects to report its first safety and effectiveness data in January.

A fourth, created by AstraZeneca and Oxford University, is a few weeks behind, and a fifth candidate, by vaccine developer Novavax of Gaithersburg, Maryland, is expected to begin its major U.S. trial shortly.

If all or most of these come through, there should be plenty of vaccine by the end of next summer to cover every American who wants one.

Contributing: Karen Weintraub

This article originally appeared on USA TODAY: COVID-19 vaccine: Police, firefighters, teachers will be next in line

Go here to see the original:

Police, firefighters, teachers will be next in line for COVID-19 vaccine - Yahoo News

Page 526«..1020..525526527528..540550..»